Fosun Pharma invests in United Family Healthcare
Shanghai Fosun Pharmaceutical Group (SSE:600196) is investing in United Family Healthcare Insurance, a related party, alongside the International Finance Corporation (IFC) and the Asian Development Bank (ADB). The three entities will invest CNY 270 million each, which will increase Fosun Pharma’s stake in United Family Healthcare from 14.00% to 20.05%. United Family Healthcare Insurance will still qualify as a joint venture. The investment is subject to regulatory approval from the China Banking and Insurance Regulatory Commission. Fosun Pharma also announced the resignation of Senior Vice President, Bao Qingui, due to personal reasons. Bao Qingui will no longer be with the company, as of March 31st, 2025. Fosun Pharma expressed their gratitude to Bao Qingui for his service to the company.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime